Low Positive Affect in Childhood May Lead to Eventual Depression

Article

Low positive affect (PA) may be a premature liability factor for unipolar depressive disorder in at-risk children.

According to a recent study, low positive affect (PA) may be a premature liability factor for unipolar depressive disorder in at-risk children, and was proven to have a greater impact than high negative affect (NA).

Thomas M. Olino from the University of Pittsburgh School of Medicine and fellow researchers analyzed the developmental trajectories of PA and NA in 202 child participants whose families had histories of depressive disorders. The children’s ages ranged from late infancy to nine years old.

The researchers determined PA and NA in the child participants in up to seven annual structured laboratory tasks.

Of the 140 mothers of the child participants, sixty had a history of juvenile-onset unipolar depressive disorder while eighty had no history of major psychopathology.

The investigators discovered that PA increased in a similar, linear fashion for all of the children as time progressed. Individual differences were seen frequently in early PA.

The children whose mothers suffered from lifetime unipolar depression were found to have perpetually lower levels of PA in comparison to the group of control participants; this finding is a significant connection, and remains so even after the researchers adjusted for current maternal depression and affect displays.

They also observed a significant linear reduction in NA in children across time, but no considerable inter-individual differences were observed in early NA or the rate of change in NA.

"Attenuated PA (rather than excessive NA) may be an early vulnerability factor for eventual unipolar depressive disorder in at-risk children and may represent one pathway through which depression is transmitted," the authors wrote.

This study is published in the July issue of the Journal of Child Psychology and Psychiatry.

Recent Videos
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Depression Screening: Challenges and Solutions at the Primary Care Level
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
HCPLive Five at APA 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.